STEMINA BIOMARKER DISCOVERY
Stemina Biomarker Discovery, Inc., a metabolomics company, focuses on the discovery, development, and commercialization of molecular biomarkers to improve drug safety and human health. The company works on collaborative research projects and joint development agreements with strategic partners to develop drugs, identify targets, and discover molecular biomarkers for the diagnosis of diseases and customized treatment. It provides metabolomics and mass spectrometry services, as well as develops di... agnostic biomarkers. The company's cell-based assays arise from the strategic convergence of technologies, such as human embryonic stem (hES) cells and metabolomics. It uses mass spectrometry to analyze the small molecules secreted by hES, heart, and neural cells in response to drugs, injury, or disease. Stemina Biomarker Discovery, Inc. was founded in 2006 and is based in Madison, Wisconsin.
STEMINA BIOMARKER DISCOVERY
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2006-01-01
Address:
Madison, Wisconsin, United States
Country:
United States
Website Url:
http://www.stemina.com
Total Employee:
11+
Status:
Active
Contact:
(608) 204-0104
Total Funding:
16.42 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Google Font API Google Tag Manager WordPress Google Analytics Content Delivery Network Global Site Tag Google Analytics 4
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Current Advisors List
Board_member
2008-01-01
Board_member
Current Employees Featured
Gabriela Cezar Co-Founder @ Stemina Biomarker Discovery
Co-Founder
2007-03-01
Elizabeth L. R. Donley CEO @ Stemina Biomarker Discovery
CEO
2006-10-01
Robert E. Burrier COO @ Stemina Biomarker Discovery
COO
Founder
Investors List
Wisconsin Investment Partners
Wisconsin Investment Partners investment in Venture Round - Stemina Biomarker Discovery
BrightStar Wisconsin Foundation
BrightStar Wisconsin Foundation investment in Venture Round - Stemina Biomarker Discovery
NeuroNetworks Fund
NeuroNetworks Fund investment in Venture Round - Stemina Biomarker Discovery
Wisconsin Investment Partners
Wisconsin Investment Partners investment in Grant - Stemina Biomarker Discovery
National Institutes of Health
National Institutes of Health investment in Grant - Stemina Biomarker Discovery
BrightStar Wisconsin Foundation
BrightStar Wisconsin Foundation investment in Venture Round - Stemina Biomarker Discovery
Madison Development Corporation
Madison Development Corporation investment in Venture Round - Stemina Biomarker Discovery
Wisconsin Investment Partners
Wisconsin Investment Partners investment in Venture Round - Stemina Biomarker Discovery
Wisconsin Investment Partners
Wisconsin Investment Partners investment in Series A - Stemina Biomarker Discovery
Phenomenelle Angels
Phenomenelle Angels investment in Series A - Stemina Biomarker Discovery
Official Site Inspections
http://www.stemina.com Semrush global rank: 5.03 M Semrush visits lastest month: 1.63 K
- Host name: stemina.com
- IP address: 199.101.50.74
- Location: Clifton Park United States
- Latitude: 42.8482
- Longitude: -73.7863
- Metro Code: 532
- Timezone: America/New_York
- Postal: 12065
More informations about "Stemina Biomarker Discovery"
Stemina Biomarker Discovery
Stemina’s Cardio quickPredict TM Identifies Proposed COVID-19 Treatment as Cardiotoxic. As reported in Science, a chloroquine COVID-19 therapy trial in Brazil was halted over risk of fatal heart complications.US FDA has also …See details»
Meet Biomarker Discovery’s Leadership Team | stemina.com
Feb 14, 2018 Stemina’s leadership team combines experience, innovation, and teamwork to accomplish the company’s scientific and strategic goals. Their areas of expertise include …See details»
Stemina Biomarker Discovery, Inc. - LinkedIn
Stemina Biomarker Discovery is a metabolomics company focused on the discovery, development, and commercialization of molecular biomarkers to improve drug safety and human health. Stemina’s cell ...See details»
Stemina Biomarker Discovery - Crunchbase
Stemina Biomarker Discovery, Inc., a metabolomics company, focuses on the discovery, development, and commercialization of molecular biomarkers to improve drug safety and human health. The company works on collaborative …See details»
Learn About Stemina Biomarker Discovery | NeuroPointDX.com
Stemina Biomarker Discovery is one remarkable corporation with two distinct business units—NeuroPointDX, focused on diagnosis and treatment of neurological disorders such as …See details»
Stemina Biomarker Discovery - Contacts, Employees, Board …
Organization. Stemina Biomarker Discovery . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. …See details»
Autism test on the horizon as firm screens for …
Feb 26, 2016 The company, Stemina Biomarker Discovery, specializes in detecting the byproducts of cellular activity and then applying high-powered statistics to detect patterns among thousands of metabolites. In August 2015, …See details»
Stemina Biomarker Discovery Company Profile - Craft
Stemina Biomarker Discovery is a metabolomics company focused on the discovery, development, and commercialization of molecular biomarkers. It offers devTOX quickPredict, a …See details»
Stemina Biomarker Discovery - Taylor & Francis Online
Aug 27, 2008 Stemina Biomarker Discovery was established in 2006 to commercialize technology developed by Dr Gabriela Cezar at the University of Wisconsin (WI, USA). …See details»
Board of Directors - Stemina Biomarker Discovery
Feb 13, 2018 The Board of Stemina Biomarker Discovery includes industry leaders with the business acumen and good judgment to lead us forward.See details»
About Stemina Biomarker - U.S. Environmental Protection Agency
About Stemina Biomarker History Founded in 2006 Raised $2.6 million in seed funding 2007 Raised $1 million angel funding 2009 Expertise Human Embryonic Stem Cell culture …See details»
Stemina biomarker discovery - PubMed
Stemina Biomarker Discovery was established in 2006 to commercialize technology developed by Dr Gabriela Cezar at the University of Wisconsin (WI, USA). Stemina's cell-based assays arise …See details»
Stemina Biomarker Discovery - Products, Competitors, Financials ...
Stemina also provides a diagnostic test for autism spectrum disorder through its NeuroPointDX division. It was founded in 2006 and is based in Madison, Wisconsin. Headquarters Location. …See details»
Stemina Biomarker Discovery - Regenerative Medicine
Stemina Biomarker Discovery was established in 2006 to commercialize technology developed by Dr Gabriela Cezar at the University of Wisconsin (WI, USA). Stemina’s cell-based assays arise …See details»
Stemina Biomarker Discovery | Madison WI - Facebook
Stemina Biomarker Discovery, Madison, Wisconsin. 98 likes · 5 were here. Human in vitro systems for toxicology and compound safety screening to improve...See details»
Scientific Advisory Board - Stemina Biomarker Discovery
Feb 12, 2018 Stemina Biomarker Discovery and its business unit NeuroPointDX both benefit from the intelligence, leadership, and experience of these professionals.See details»
STEMina
At STEMina, we prioritize helping students build internal structures and motivations that foster continued engagement and dedication in their learning environments, ensuring long-term …See details»
Stemina Poster: A Human Pluripotent Stem Cell-based Assay …
A Human Pluripotent Stem ell-ased Assay Accurately Predicts the Developmental Toxicity Potency for a Series of Valproate Analogues Jessica Palmer1, Robert urrier1, Elizabeth …See details»
Comparison of the Stemina devTOX quickPredict system with …
Stemina BIOMARKER DISCOVERY The dose-response curve for the o/c ratio (purple curve) is fit using a non-linear four-parameter log-logistic model. This curve is used to interpolate the …See details»